Advanced search
Publication Cover
Acta Cardiologica Volume 70, 2015 - Issue 2
Submit an article Journal homepage
26
Views
4
CrossRef citations to date
0
Altmetric
Articles

The additive value of multiple biomarkers in prediction of premature coronary artery disease

Sungsoo ChoDivision of Cardiology, Cardiovascular Research Institute, Dept. of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
, Md;,
Sang Hak LeeDivision of Cardiology, Cardiovascular Research Institute, Dept. of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
, Md, Phd;,
Sungha ParkDivision of Cardiology, Cardiovascular Research Institute, Dept. of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
, Md, Phd;,
Sun Ha JeeEpidemiology and Health Promotion, Yonsei University, Seoul, Korea.
, Phd;,
Myeong Ki HongDivision of Cardiology, Cardiovascular Research Institute, Dept. of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
, Md, Phd;,
Namsik ChungDivision of Cardiology, Cardiovascular Research Institute, Dept. of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
, Md, Phd;,
Seung Yun ChoDivision of Cardiology, Cardiovascular Research Institute, Dept. of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
, Md, Phd; &
Yangsoo JangDivision of Cardiology, Cardiovascular Research Institute, Dept. of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.Correspondence[email protected]
, Md, Phd show all
Pages 205-210 | Received 04 Apr 2014, Accepted 04 Dec 2014, Published online: 23 May 2017

  • Braunwald E. Shattuck lecture --cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337:1360–9.
  • Haidari M, Javadi E, Sanati A, Hajilooi M, Ghanbili J. Association of increased ferritin with premature coronary stenosis in men. Chu Chem 2001; 47: 1666–72.
  • Haidari M, Javadi E, Sadeghi B, Hajilooi M, Ghanbili J. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Chu Biochem 2001; 34: 309–15.
  • Danesh J, Wheeler JG, Hirschfield GM, Eda S. Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387–97.
  • Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767–72.
  • Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006; 113:2335–62.
  • Kampoli A-M, Tousoulis D, Papageorgiou N, Pallatza Z, Vogiatzi G, Briasoulis A, Androulakis E, Toutouzas C, Stougianos P. Tentolouris C, Stefanadis C. Clinical utility of biomarkers in premature atherosclerosis. CurrMedChem 2012; 19:2521–33.
  • Mahajan N, Malik N, Bahl A, Dhawan V. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease. Atherosclerosis 2009; 207: 597–602.
  • Bouhali T, Brisson D, St-Pierre J, Tremblay G, Perron P. Laprise C, Vohl M-C, Vissers MN, Hutten BA, Després J-P, Kastelein JJ, Gaudet D. Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia. Atherosclerosis 2008; 196:262–9.
  • Koh SJ, Kim JY, Hyun YJ, Park SH, Chae JS, Park 5, Kim J-5, Youn JC, Jang Y, Lee JH. Association of serum RANTES concentrations with established cardiovascular risk markers in middle-aged subjects. Int J Cardiol 2009; 132: 102–8.
  • Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu 5, Larsson A, Venge P. ArnI8v J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358:2107–16.
  • Wang TJ, Gona P. Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D’Agostino RB, Vasan RS. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355:2631–9.
  • Erzen B, Sabovic M, Poredos P. Sebestjen M, Keber I, Simcic S. Inflammation markers in young post-myocardial patients exhibiting various expressions of classic coronary risk factors. Coron Artery Dis 2006; 17: 325–30.
  • Speidl WS, Graf 5, Hornykewycz 5, Nikfardjam M, Niessner A, Zorn G, Wojta J, Huber K. High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease. Am Heart J 2002; 144:449–55.
  • van Loon JE, de Maat MPM, Deckers JW, van Domburg RT, Leebeek FWG. Prognostic markers in young patients with premature coronary heart disease. Atherosclerosis 2012; 224:213–7.
  • Downs JR, Clearfield M, Weis 5, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotta AM Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279:1615–22.
  • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised Placebo-controlled trial. Lancet 2002; 360: 7–22.
  • Jang Y, Kim OY, Hyun YJ, Chae JS, Koh SJ, Heo YM, Choi D, Shin D-J, Huttner K, Lee JH. Interleukin-6-572C> G polymorphism-association with inflammatory variables in Korean men with coronary artery disease. Transl Res 2008; 151: 154–61.
  • Ndrepepa G, Braun 5, Tada T, Guerra E, Schunkert H, Laugwitz K-L, Kastrati A. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy. Cardiovasc Revasc Med 2014; 15: 131–6.
  • Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM Jr, Kastelein JJP, Koenig W, Libby P. Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359:2195–207.
  • Kannel WB. Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 2002; 11: 101–7.
  • Kannel WB, D’Agostino RB. The Importance of Cardiovascular Risk Factors in the Elderly. Am J Geriatr Cardiol 1995; 4: 10–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.